Is TCRR or QYLD a better dividend investment in 2026?

TCRR currently yields 135.14% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: TCRR offers higher current income.

What is the dividend yield difference between TCRR and QYLD?

TCRR has a forward dividend yield of 135.14% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 123.22 percentage points.

Home › Compare › TCRR vs QYLD

TCRR vs QYLD: Dividend Comparison 2026

TCRR yields 135.14% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TCRR wins by $14.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TCRR

● Live price

135.14%

Share price

$1.48

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$14.90M

Annual income

$6,066,079.91

Full TCRR calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — TCRR vs QYLD

📍 TCRR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TCRR	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TCRR + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TCRR pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCRR

Annual income on $10K today (after 15% tax)

$11,486.49/yr

After 10yr DRIP, annual income (after tax)

$5,156,167.92/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, TCRR beats the other by $5,151,357.51/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCRR + QYLD for your $10,000?

TCRR: 50%QYLD: 50%

100% QYLD50/50100% TCRR

Portfolio after 10yr

$7.46M

Annual income

$3,035,869.62/yr

Blended yield

40.69%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on TCRR right now

TCRR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$5.00

+237.8% upside vs current

Range: $5.00 — $5.00

Altman Z

-7.2

Piotroski

2/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCRR buys

QYLD buys

No recent congressional trades found for TCRR or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTCRRQYLD

Forward yield	135.14% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$14.90M	$25.4K ✓
Annual income after 10y	$6,066,079.91 ✓	$5,659.31
Total dividends collected	$13.68M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: TCRR vs QYLD ($10,000, DRIP)

Year	TCRR Portfolio	TCRR Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$24,214	$13,513.51	$10,352	$1,192.36	+$13.9K → TCRR
2	$56,489	$30,580.34	$10,830	$1,347.57	+$45.7K → TCRR
3	$127,118	$66,675.01	$11,460	$1,539.07	+$115.7K → TCRR
4	$276,241	$140,224.56	$12,275	$1,777.84	+$264.0K → TCRR
5	$580,365	$284,787.59	$13,323	$2,078.95	+$567.0K → TCRR
6	$1,180,170	$559,178.96	$14,667	$2,463.34	+$1.17M → TCRR
7	$2,325,480	$1,062,698.63	$16,396	$2,960.57	+$2.31M → TCRR
8	$4,445,281	$1,957,016.59	$18,631	$3,612.97	+$4.43M → TCRR
9	$8,252,658	$3,496,207.78	$21,548	$4,482.15	+$8.23M → TCRR
10	$14,896,424	$6,066,079.91	$25,398	$5,659.31	+$14.87M → TCRR

TCRR vs QYLD: Complete Analysis 2026

TCRR — Stock

TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Full TCRR Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this TCRR vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCRR vs SCHD TCRR vs JEPI TCRR vs O TCRR vs KO TCRR vs MAIN TCRR vs XYLD TCRR vs JEPQ TCRR vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.